ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study.

MLA

Rodriguez-Wallberg, Kenny A., et al. “ProFertil Study Protocol for the Investigation of Gonadotropin-Releasing Hormone Agonists (GnRHa) during Chemotherapy Aiming at Fertility Protection of Young Women and Teenagers with Cancer in Sweden-a Phase III Randomised Double-Blinded Placebo-Controlled Study.” BMJ Open, vol. 13, no. 12, Dec. 2023, p. e078023. EBSCOhost, https://doi.org/10.1136/bmjopen-2023-078023.

APA

Rodriguez-Wallberg, K. A., Nilsson, H. P., Bergh, J., Malmros, J., Ljungman, P., Foukakis, T., Stragliotto, C. L., Friman, E. I., Linderholm, B., Valachis, A., Andersson, A., Harrysson, S., Vennström, L., Frisk, P., Mörse, H., & Eloranta, S. (2023). ProFertil study protocol for the investigation of gonadotropin-releasing hormone agonists (GnRHa) during chemotherapy aiming at fertility protection of young women and teenagers with cancer in Sweden-a phase III randomised double-blinded placebo-controlled study. BMJ Open, 13(12), e078023. https://doi.org/10.1136/bmjopen-2023-078023

Chicago

Rodriguez-Wallberg, Kenny A, Hanna Pauline Nilsson, Jonas Bergh, Johan Malmros, Per Ljungman, Theodoros Foukakis, Christina Linder Stragliotto, et al. 2023. “ProFertil Study Protocol for the Investigation of Gonadotropin-Releasing Hormone Agonists (GnRHa) during Chemotherapy Aiming at Fertility Protection of Young Women and Teenagers with Cancer in Sweden-a Phase III Randomised Double-Blinded Placebo-Controlled Study.” BMJ Open 13 (12): e078023. doi:10.1136/bmjopen-2023-078023.